The government is considering expanding taxpayer subsidies for Ozempic-style drugs, despite concerns about possible ...

A new drug by pharmaceutical giant Eli Lilly rivaling Ozempic and Wegovy could lead to 'significantly' more weight loss after ...

Bengaluru: New findings presented at ObesityWeek® 2025 have unveiled promising results for an investigational daily pill ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

A next-generation obesity shot from Eli Lilly and Co. helped patients lose almost a quarter of their body weight, potentially ...

Eli Lilly said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after ...

Using a kind of novel linker technology, the startup is developing versions of incretin and non-incretin therapies that can ...

Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity ...

Oral semaglutide for weight loss could be a game-changer for obesity care in India: Our Bureau, Mumbai Thursday, December 11, 2025, 15:30 Hrs [IST] New findings presented at Obesi ...

The slump has virtually wiped out several years of stellar gains that came after Novo’s Wegovy drug was approved as a ...